Stevens Capital Management LP Novo Cure LTD Transaction History

Stevens Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$68.3 - $93.8 $619,071 - $850,203	-9,064 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$61.86 - $97.8 $560,699 - $886,459	9,064 New	9,064 $678,000
Q2 2019 Jul 31, 2019	SELL	$42.22 - $63.23 $1.63 Million - $2.44 Million	-38,647 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$31.96 - $56.12 $596,181 - $1.05 Million	18,654 Added 93.3%	38,647 $1.86 Million
Q4 2018 Feb 06, 2019	BUY	$28.72 - $52.63 $574,198 - $1.05 Million	19,993 New	19,993 $669,000

265

77.1M

751K

293K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.59B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.